WA
WST icon

Wasatch Advisors’s West Pharmaceutical WST Stock Holding History

Wasatch Advisors’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.86M Buy
+24,670
New +$7.54M 0.06% 147

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Wasatch Advisors's WST Position: Q2 2026 in Review

Wasatch Advisors opened a new position in West Pharmaceutical (WST) in Q2 2026: 24,670 shares worth $8.86M. The stake represents 0.06% of the portfolio and ranks #147 among its holdings.

830 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Wasatch Advisors held 24,670 shares of West Pharmaceutical worth $8.86M as of Q2 2026.
  • West Pharmaceutical was a new Wasatch Advisors position in Q2 2026.
  • West Pharmaceutical made up 0.06% of Wasatch Advisors's portfolio in Q2 2026, its #147 holding.
  • 830 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Wasatch Advisors's 13F filing for Q2 2026, filed 10 Jul 2026.